Sugarlogix Announces Relaunch as NAMUH
Company Will Close Nutritional Gap Between Infant Formula and Human MilkALAMEDA, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Sugarlogix, a...
Year: 2022
Simcha Therapeutics Raises $40 Million Series B Financing and Initiates Phase 1/2 Study to Evaluate Novel Interleukin-18 Variant in Cancer
Financing led by SR One; Proceeds to advance proprietary IL-18 variant through Phase 2 clinical trial ST-067 is a first-in-class...
Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu Nhwa Pharmaceutical
Submission supported by data from a Phase 3 bridging study of oliceridine injection compared to IV morphine, conducted in China...
SmileDirectClub Advances Whitening Portfolio with Launch of Wireless Pro Whitening System Plus
Latest Advancement in Oral Care Increases Access to Innovative Teeth Whitening for a Brighter, Healthier Smile SmileDirectClub Pro Whitening System...
Option Care Health to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call
BANNOCKBURN, Ill., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest...
Assure Sets Managed Cases Record for Full-Year, Fourth Quarter and Month of December 2021
DENVER, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider...
Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences
Data to be presented suggests ACER-001 could represent a potential alternative to sodium and glycerol phenylbutyrate for treatment of UCDsNEWTON,...
Ensysce Biosciences Announces Results of Special Meeting of Stockholders
SAN DIEGO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a...
Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 Patients
§ Phase 2 Study NLC-V-01 closed early after interim data analysis due to positive clinical efficacy § Primary endpoint of...
Perimeter Medical Imaging AI Announces Closing of Strategic Private Placement to Social Capital
TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven...
Kareo Telehealth Enables The Weichman Clinic to Expand Access to Mental Health Care for Adolescents
Prominent Southern California Provider Adopts Fully Integrated Suite of Solutions IRVINE, Calif.--(BUSINESS WIRE)--Kareo, the leading provider of cloud-based clinical and...
Ted Davis to Succeed Amy Tseng as President and CEO of TissueTech
MIAMI--(BUSINESS WIRE)--TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease...
HCA Healthcare Reports Fourth Quarter 2021 Results and Provides 2022 Guidance
Company Increases Capital Spending, Authorizes Additional Share Repurchase Program and Increases Quarterly Dividend NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA)...
Zomedica Provides Updates on PulseVet Sales & Marketing Integration and Marketing Activities for the First Quarter of 2022
ANN ARBOR, MI / ACCESSWIRE / January 27, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Novel Data in Alzstatin Alzheimer’s Project Presented at the 11th Pharmaceutical Profiling Meeting
STOCKHOLM, SWEDEN / ACCESSWIRE / January 27, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical...
XVIVO Presents Report on Operations 2021
GOTHENBURG, SWEDEN / ACCESSWIRE / January 27, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)Year ends on strong quarterFourth quarter...
Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from Right to Try Use of Aviptadil During Omicron Surge
GENEVA, SWITZERLAND / ACCESSWIRE / January 27, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to...
Taylor Benefits Insurance Agency is Pleased to Announce That It Experienced a 25 Percent Increase in California Group Health Insurance and Employee Benefit Plan Customers in 2021, Compared to 2020
The Company, Which is an Independent Insurance Brokerage Agency, Also Experienced the Same Increase in its California Employee Benefit Plan...
Physicians Thrive Releases The 2022 Edition Of Annual Physician Compensation Report
OMAHA, Neb., Jan. 27, 2022 /PRNewswire/ -- Physicians Thrive is pleased to announce the 2022 Physician Compensation Report is now...
United States e-Prescribing Market Report 2022-2027 Featuring Prominent Vendors – Athenahealth, Cerner, DrFirst, Henry Schein, InSync Healthcare Solutions, Practice Fusion, & Surescripts
DUBLIN, Jan. 26, 2022 /PRNewswire/ -- The "U.S. E-Prescribing Market - Industry Outlook & Forecast 2022-2027" report has been added...